Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (990) Arrow Down
Filter Results: (990) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (990)
    • People  (4)
    • News  (256)
    • Research  (615)
    • Events  (9)
    • Multimedia  (24)
  • Faculty Publications  (396)

Show Results For

  • All HBS Web  (990)
    • People  (4)
    • News  (256)
    • Research  (615)
    • Events  (9)
    • Multimedia  (24)
  • Faculty Publications  (396)
← Page 34 of 990 Results →
  • Web

Consumer Information | MBA

Disabilities Career and Professional Development Drug and Alcohol Prevention Retention and Graduation Rates Campus Security Fire Safety Student Records Policy (FERPA) University Wide Consumer Information View Details

    John J. Horan

    Through heavy investments in research and development, Horan led Merck to become the leading U.S.-based manufacturer of prescription drugs in the world. Under Horan’s leadership, Merck doubled their spending on research – spending more... View Details
    Keywords: Healthcare
    • 10 Oct 2017
    • First Look

    First Look at New Research and Ideas, October 10, 2017

    in the diabetic space, became MannKind’s marketing partner and helped launch Afrezza in February, 2015. Although the drug had a black box warning and required doctors to perform a lung test on patients, expectations were high, with some... View Details
    Keywords: Sean Silverthorne
    • Web

    1. Standards of Conduct | MBA

    2.3 Community Standards of Conduct 2.3.1 Drug & Alcohol Policy 2.3.2 Hazing 2.3.3 Non-Discrimination & Anti-Bullying 2.3.4 Sexual & Gender Based Harassment & Other Sexual Misconduct 2.3.5 Research Misconduct 2.3.6 Dangerous Weapons &... View Details
    • 19 Sep 2017
    • First Look

    First Look at New Research and Ideas, September 19

    time, Imprimis was in the process of seeking FDA approval for a branded drug called Impracor. This process, already difficult, was further complicated by recent manufacturing issues. Meanwhile, the opportunity arose for Imprimis to... View Details
    Keywords: Sean Silverthorne

      Robert F. Dee

      During his CEO tenure, Dee achieved an 800% increase in revenues (over $3 billion) – moving SmithKline into the upper echelons of major pharmaceutical organizations. He introduced the anti-ulcer medication, Tagamet, which became the largest selling prescription View Details
      Keywords: Healthcare
      • 17 Jun 2019
      • Blog Post

      Why I Would Have Applied to the MS/MBA Biotechnology: Life Sciences Program

      and drug development. These qualities straddle the science and business fields – for example, to instill a science-focused culture within an organization, or to craft a drug development strategy that... View Details

        William B. Bell

        coating resins, as well as melamine resins, which were used in making work surfaces impervious to scratches and stains. During the 1940s and 50s, Bell also expanded American Cyanamid's activities in drug research and production. View Details
        Keywords: Chemicals & Industrial
        • 01 Sep 2011
        • News

        Alumni Team Up to Fight Cancer

        networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details
        Keywords: biomedicine; Ambulatory Health Care Services; Health, Social Assistance
        • 01 Mar 2017
        • News

        How Deep Brain Stimulation Could Change Medicine

        targeted approach gives Bennet hope that Harmoni can benefit not only people suffering from movement disorders, but also a whole class of psychiatric patients who, until now, had few options beyond prescription drugs to help lessen the... View Details
        Keywords: Janelle Nanos

          Josiah K. Lilly

          Lilly, a trained pharmacist and the founder of the family drug manufacturer, set up the first scientific division in the company and focused on standards of manufacturing and scientific development. Among other products, the company... View Details
          Keywords: Healthcare
          • 01 Mar 2008
          • News

          The Last Frontier

          state for people with debilitating but nonterminal diseases like his to receive, with a doctor’s assistance, drugs with which they may take their own lives. Explained Gardner, “Why do this? I want to be involved in public life. I was... View Details
          Keywords: William Booth Gardner; MBA 1963; physician-assisted suicide; Government; Health, Social Assistance

            Randall L. Tobias

            The first outsider to run the company, Tobias is credited with orchestrating a major turnaround of Eli Lilly. Under his direction, Lilly introduced two successful drugs (Zyprexa for schizophrenia and Gemzar for cancer), solidified and... View Details
            Keywords: Healthcare
            • 29 Jun 2022
            • Blog Post

            Harvard Business School Announces the 2022-2023 Blavatnik Fellows

            medicines. Hunter plans to use the Blavatnik Fellowship year to refine strategy and business development for the company’s novel drug delivery platform with his co-founders, Harvard Medical School Professor Dr. Wayne Lencer and Justin... View Details
            • 24 Apr 2014
            • News

            Finding a cure so that others may benefit

            call. The foundation wanted to invest in for-profit bioscience companies to spur scientists to find a cure for the disease. O’Donnell is credited with almost singlehandedly raising $250 million in support of this venture philanthropy, which led to the development of... View Details
            • 01 Dec 2004
            • News

            Finding a Balance

            Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that manufactures and sells... View Details
            Keywords: Julia Hanna; Colleges, Universities, and Professional Schools; Educational Services
            • 27 Jun 2005
            • Research & Ideas

            The Potential Downside of Win-Win

            consideration for all managers. Value Creation—and Collusion Suppose that pharmaceutical firm A manufactures a new, beneficial drug and begins selling 100 million pills per year at $3.05 per pill. Each pill costs 5 cents to manufacture,... View Details
            Keywords: by Max H. Bazerman
            • 18 Sep 2014
            • News

            Room to grow: global expansion in the middle ground

            consulting firm Shaldor, documents the specific strategies various companies pursued. As examples, by focusing on a neglected market segment, Netafim became the world leader in drip irrigation technology, while Teva Pharmaceutical created a scalable, acquisition-based... View Details
            • 07 Apr 2003
            • Research & Ideas

            Three Steps for Crisis Prevention

            South Africa over its attempt to reduce the cost of HIV drugs through parallel importation (buying pharmaceuticals in countries with lower prices and then importing them) and compulsory licensing (requiring patent holders to allow others... View Details
            Keywords: by Michael D. Watkins & Max H. Bazerman
            • 01 Aug 2001
            • News

            Cleveland Global Alumni Conference a Sold-Out Success

            investment in math and physical sciences. Moving on to challenges Merck has faced, Gilmartin explained that new drug discovery tools have increased the speed at which its competitors can introduce new products to the marketplace, even as... View Details
            Keywords: Hanna, Julia; Frank Batten (MBA '52); Colleges, Universities, and Professional Schools; Educational Services
            • ←
            • 34
            • 35
            • …
            • 49
            • 50
            • →
            ǁ
            Campus Map
            Harvard Business School
            Soldiers Field
            Boston, MA 02163
            →Map & Directions
            →More Contact Information
            • Make a Gift
            • Site Map
            • Jobs
            • Harvard University
            • Trademarks
            • Policies
            • Accessibility
            • Digital Accessibility
            Copyright © President & Fellows of Harvard College.